Next Article in Journal
Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model
Next Article in Special Issue
Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
Previous Article in Journal
Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma
Previous Article in Special Issue
Technology of Orodispersible Polymer Films with Micronized Loratadine—Influence of Different Drug Loadings on Film Properties
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(3), 257; https://doi.org/10.3390/pharmaceutics12030257
Action Date Notes Link
article xml file uploaded 12 March 2020 11:54 CET Original file -
article xml uploaded. 12 March 2020 11:54 CET Update https://www.mdpi.com/1999-4923/12/3/257/xml
article pdf uploaded. 12 March 2020 11:54 CET Version of Record https://www.mdpi.com/1999-4923/12/3/257/pdf
article html file updated 12 March 2020 11:56 CET Original file -
article html file updated 1 April 2020 17:56 CEST Update -
article html file updated 20 July 2022 22:42 CEST Update https://www.mdpi.com/1999-4923/12/3/257/html
Back to TopTop